SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000864047-96-000101
Filing Date
1996-06-10
Accepted
1996-06-10 00:00:00
Documents
1
Group Members
INVESCO FUNDS GROUP, INC.INVESCO NORTH AMERICAN GROUP, LTD.INVESCO NORTH AMERICAN HOLDINGS, INC.INVESCO PLCINVESCO, INC.
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 SC 13G 17000
  Complete submission text file 0000864047-96-000101.txt   19231
Mailing Address 11 DEVONSHIRE SQUARE LONDON EC2M 4YR X0
Business Address 11 DEVONSHIRE SQUARE LONDON EC2M 4YR X0 011447162634
INVESCO PLC (Filed by) CIK: 0000864047 (see all company filings)

State of Incorp.: CO | Fiscal Year End: 1231
SIC: 0000

Mailing Address 400 OYSTER POINT BLVD SUITE 605 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 605 SAN FRANCISCO CA 94080 4152444880
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

IRS No.: 93171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-46083 | Film No.: 96578651
SIC: 2836 Biological Products, (No Diagnostic Substances)